HB0887

Find a 2017 Bill:

2017 Regular Session

 

Entitled:

Health Insurance - Prior Authorization for Drug Products to Treat an Opioid Use Disorder - Prohibition

Sponsored by:

Delegate Pena-Melnyk

Status:

In the House - Returned Passed


Synopsis:Prohibiting specified insurers, nonprofit health service plans, and health maintenance organizations from applying a preauthorization requirement for a prescription drug to be used for treatment of an opioid use disorder and that contains methadone, buprenorphine, or naltrexone; and applying the Act to all policies, contracts, and health benefit plans issued, delivered, or renewed in the State on or after the effective date of the Act.
Analysis:Fiscal and Policy Note (Revised)
All Sponsors:Delegates Pena-Melnyk, Angel, Barron, Kelly, McMillan, Tarlau, Bromwell, Cullison, Hayes, Hill, Kipke, Krebs, McDonough, Metzgar, Miele, Morales, Morgan, Pendergrass, Platt, Rosenberg, Saab, Sample-Hughes, Szeliga, West, K. Young, and Frick
Additional Facts:Bill is an Emergency Bill
Bill File Type: Regular
Effective Date(s): Upon Enactment
Committee(s):
Health and Government Operations  View Committee HearingFinance  View Committee Hearing
Broad Subject(s):Insurance - Health
Public Health
Narrow Subject(s):Contracts -see also- Land Installment Contracts; Procurement
Drugs -see also- Controlled Dangerous Sub; Substance Abuse
Emergency Bills
Health Insurance -see also- HMOS; Managed Care Organizations
Health Maintenance Organizations -see also- Manage Care Orgs
Nonprofit Organizations
Pharmacy Benefits Managers
Substance Abuse
Statutes:Article - Insurance
(15-850)

How a Bill Becomes Law

Legislative Lingo

Explanation of Floor Motions and Actions


April 5, 2017 3:52 P.M.